The Lancet in conversation with

Nick James discusses the key messages of the recent report from the STAMPEDE trial platform and the success of this platform in advancing the treatment of prostate cancer 

Continue this conversation on social!

《柳叶刀》亚洲执行主编王辉对话《柳叶刀中国女性生殖、孕产妇、新生儿、儿童和青少年健康重大报告》共同主席乔杰院士。

Continue this conversation on social!

Helena Wang discusses The Lancet Commission on women's reproductive, maternal, newborn, child and adolescent health (RMNCAH) in China with author Professor Jie Qiao.

Continue this conversation on social!

Siobhan Quenby & Arri Coomarasamy discuss the key findings from The Lancet's new Series on miscarriage.

Continue this conversation on social!

On the 50th anniversary of the Inverse Care Law, Professor Sir Muir Gray joins Gavin Cleaver to discuss the continuing importance of the ICL, and notions of value and quality in health care.

Continue this conversation on social!

The Lancet's new Commission, Public Policy and Health in the Trump Era, looks back at the effects of the last four years on the health of the USA. One of the authors of the Commission, Mary Bassett (Harvard University) joins us to talk about the Commission findings and wider issues facing the USA.

Continue this conversation on social!

Editor-in-chief of The Lancet, Richard Horton, discusses the results of the Oxford vaccine's phase 3 trial.

Continue this conversation on social!

Renee Salas, leader of the Lancet Countdown policy brief in the US, discusses the climate problems facing the US, the issues of the last four years, and the reasons to be optimistic about the future.

Continue this conversation on social!

Universal health coverage (UHC) is a vital facet of healthcare across the world, and a new Global Burden of Disease paper seeks to measure its spread. The Lancet spoke with  author Rafael Lozano and linked Comment author Margaret Kruk about efforts to analyse and measure UHC.

Continue this conversation on social!

The Lancet Editor-in-Chief Richard Horton explains the current status of the Oxford and China COVID-19 vaccines, including an overview of current progress and the next steps for both.

Continue this conversation on social!